Erik Hirsch is Co-Chief Executive Officer of Hamilton Lane, where he is responsible for the firm’s strategic direction and operations. The firm currently has over $900 billion in assets under management and supervision and is committed to driving meaningful change in private markets for the institutions and other clients that it serves.
SEARCH RESULTS
Results for "Markets"
258. Varun Laijawalla of Ninety One: Emerging Markets Unpacked
Varun Laijawalla is a Portfolio Manager at Ninety One, where he manages long only EM and EM ex-China portfolios. He started his career as a consultant and moved into stockpicking via Asia focused sales.
BONUS Episode: Avivah Wittenberg-Cox: Higher for Longer is not just for markets – Preparing for the 100 year and 4 Quarter life
In this bonus episode we meet with fellow INSEAD alumna Avivah Wittenberg-Cox advocates for new thinking in generational and gender balance. She is a consultant, coach and speaker on the rising impact of longevity on the people and on the workplace and provides advice to help businesses thrive. She is the author of seven books on gender, leadership and longevity and the host of the podcast 4-Quarter lives, where she applauds podcasts as a way to create “real conversations in a very noisy world”.
245. Randy Cohen, Senior Lecturer at Harvard Business School – Dangerous Vision in Stock Markets and Venture Capital
Randy Cohen, is a Senior Lecturer at Harvard Business school. His main research focus is the interface between the actions of institutional investors and price levels in the stock market and has helped to start and grow a number of investment management firms. He is a partner at Exsight Capital, a venture capital firm specializing in early-stage impact investments in innovative ophthalmic diagnostic and treatment solutions. This has particular resonance for Randy, who is blind from retinitis pigmentosa.
234. Uwe Schillhorn or Emerging Markets Investor Alliance: Uncertainty and Navigating it in the World of Investing
Uwe Schillhorn is Program Director at Emerging Markets Investors Alliance. He previously was CIO at Principal International Americas, where he managed the investment teams and developed the business in Latin America. Prior to that he was previously a global bond portfolio manager at UBS, and his most recent role was as CIO of a Chicago based public fund.
Episode 227: Saira Malik of Nuveen: Investing in Markets and In Oneself – A Multi-Generational Proof Statement
Saira Malik is Chief Investment Officer at Nuveen, a TIAA company. She is an active voice on social media, regularly posting videos on LinkedIn containing market related and career related content. She recently celebrated her 20th anniversary at Nuveen.
Episode 226: Katie Stitch: Primary Thoughts on Secondary Markets
Katie Stitch is a partner at W Capital Partners, a private equity firm based in the NYC area that provides secondary liquidity solutions to private company shareholders and to PE/VC investment firms. She has held a number of Board roles and started her career as an analyst in investment banking.
196. Duncan MacInnes of Ruffer: The art of MiniMax Regret and Portfolio Construction in Today’s Markets
Duncan McInnes is an Investment Director at Ruffer LLP, where he has spent over a decade. He previously worked in wealth management. I have enjoyed listening to Duncan discuss positioning and multi-asset insights on the conference circuit and wanted to take this opportunity to discuss his views on the current macro backdrop as well as the state of play in finance circles as we wrestle with failing banks and what this means for investors.
18. Shalom Lloyd of Emerging Markets Quality Trials: Transforming Healthcare through Research in Africa
Shalom Lloyd, after a career of over 20 years in the pharmaceutical industry, went on to found two businesses. She is founder of Naturally Tribal skincare, a beauty line based on traditional remedies including shea butter, which she developed initially to cure her son’s eczema. She is also the co-founder and Chief Strategy Officer of eMQT, described as “the Bridge between the Pharmaceutical Industry and Africa” which facilitates clinical trials for pharmaceutical companies in Africa. She has been a keynote speaker on the topic of innovation and was a fellow of the Start-Up Leadership Program in London until 2020.
9. Shalom Lloyd of Emerging Markets Quality Trials: Transforming Healthcare through Research in Africa
Shalom Lloyd, after a career of over 20 years in the pharmaceutical industry, went on to found two businesses. She is founder of Naturally Tribal skincare, a beauty line based on traditional remedies including shea butter, which she developed initially to cure her son’s eczema. She is also the co-founder and Chief Strategy Officer of eMQT, described as “the Bridge between the Pharmaceutical Industry and Africa” which facilitates clinical trials for pharmaceutical companies in Africa. She has been a keynote speaker on the topic of innovation and was a fellow of the Start-Up Leadership Program in London until 2020.